Abstract
To compare mexidol with control molecules (choline alfoscerate, piracetam, glycine, semax) using chemoreactome analysis. The chemical structure of mexidol was compared to molecule metabolites extracted from the Human Metabolome Database (HMDB) and a drug database. More than 40 000 of metabolites from HMDB were used as a model of human metabolome. The chemoreactome analysis showed that mexidol may be (1) an agonist of acetylcholine and GABA-A receptors; (2) an anti-inflammatory agent, the effects of which are carried out by inhibiting the synthesis of pro-inflammatory prostaglandins; (3) a neurotrophic agent with neuroprotective properties; (4) a coagulation inhibitor; (5) a diabetes medication and (6) a hypolipidemic agent. Compared to 'control' molecules, mexidol has a more pronounced safety profile (a lower impact on serotonin, dopamine and adrenergic receptors, a lesser degree of interaction with the potassium channels of the heart, MAO and P450 cytochromes). The results of modeling allow to specify the mechanisms of action of mexidol at the molecular level.
References
Jan 31, 1997·Journal of Medicinal Chemistry·N H LinM W Holladay
Jun 19, 1998·Brain Research. Molecular Brain Research·T NishizakiK Sumikawa
Apr 7, 2000·Brain Research·Y LiE M Meyer
Jun 24, 2004·Toxicology·Ke-Ren ShanZhi-Zhong Guan
Dec 8, 2005·DNA and Cell Biology·Jolanta DorszewskaWojciech Kozubski
Mar 24, 2006·Nature·Michael C Sanguinetti, Martin Tristani-Firouzi
Jan 5, 2007·Nucleic Acids Research·David S WishartLori Querengesser
Mar 21, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Anil Bhanudas GaikwadPoduri Ramarao
Jul 26, 2012·Neuropharmacology·Michiko Nakamura, Il-Sung Jang
Oct 15, 2013·British Journal of Pharmacology·Lawren VandevredeGregory R Thatcher
Apr 16, 2014·Neuroscience·E AvolioM Canonaco
May 9, 2014·Current Topics in Medicinal Chemistry·Rodolpho C BragaCarolina H Andrade
May 13, 2014·Cell Transplantation·Wise Young
Aug 26, 2014·Biochemical Pharmacology·Zhen GaoYu Huang
Aug 27, 2014·PloS One·Zhenying HanHua Su
Jul 28, 2015·Biochemical Pharmacology·Elisa NavarroManuela G Lopez
Jun 29, 2016·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Siripong PaleeNipon Chattipakorn
Jul 31, 2016·British Journal of Pharmacology·Maria C OlianasPierluigi Onali
Sep 30, 2016·Experimental Dermatology·Agatha Stegemann, Markus Böhm
Citations
Dec 1, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O A GromovaA G Nazarenko
Jul 1, 2017·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·L V StakhovskayaL A Shepankevich
Apr 21, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·I A StrelnikovaO V Androfagina
Oct 19, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O A GromovaO V Tikhonova
Jun 12, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·D M PlotnikovO I Aliev
Dec 22, 2021·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A I FedinO D Ostroumova